Kazia Therapeutics Limited (KZIA) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear

Kazia Therapeutics Limite...

NASDAQ: KZIA · Real-Time Price · USD
6.56
0.25 (3.96%)
At close: Oct 03, 2025, 3:59 PM
6.42
-2.14%
After-hours: Oct 03, 2025, 07:51 PM EDT

Kazia Therapeutics Ratios and Metrics

Financials in AUD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
PE Ratio
-0.29 -1.57 -3.22 -18.37
PEG Ratio
n/a 0.04 -0.02 0.33
PS Ratio
3.38 57.81K 8.06K 10.19
PB Ratio
-0.78 2.66 4.32 4.09
P/FCF Ratio
-0.82 -2.12 -3.54 -16.98
P/OCF Ratio
-0.82 -2.12 -3.54 -16.98
OCF/S Ratio
-4.15 -27.31K -2.28K -0.6
Debt / Equity Ratio
-0.06 0.15 0.10 n/a
Quick Ratio
0.24 1.93 1.40 3.54
Current Ratio
0.24 1.42 1.40 3.53
Asset Turnover
0.11 0.00 0.00 0.26
Interest Coverage
n/a n/a -12.13K n/a
Return on Equity
2.67 -1.7 -1.34 -0.22
Return on Assets
-1.24 -0.73 -0.72 -0.14
Return on Invested Capital
7.88 -1.1 -0.78 -0.14
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 1.00 1.00
Net Profit Margin
-11.6 -36.87K -2.5K -0.55
Pretax Profit Margin
-11.72 -37.36K -2.54K -0.59
Operating Profit Margin
-12.33 -43.47K -2.54K -0.42
FCF Margin
-4.15 -27.31K -2.28K -0.6
EBITDA Margin
-11.6 -40.14K -2.35K -0.34